Genetic Testing for Opioid Risk and Drug Metabolism: A Pain Clinic's Retrospective Cohort Study

Pharmacogenetics hold promise as an important clinical tool to individualize chronic pain treatment. Prescribing based on drug metabolism and other unique genetic characteristics can potentially decrease inherent risks of chronic opioid therapy. This IRB-approved retrospective study addressed the primary research question: Is there a significant association between genetic test results evaluating drug metabolism and clinical decision-making six months after the initial genetic test results?
Source: Pain Management Nursing - Category: Nursing Authors: Source Type: research